Novel compounds and methods of using those compounds for the treatment of inflammatory conditions are provided. In a preferred embodiment, modulation of the activation state of p38 kinase protein comprises the step of contacting the kinase protein with the novel compounds.
申请公布号
WO2004060306(A2)
申请公布日期
2004.07.22
申请号
WO2003US41449
申请日期
2003.12.26
申请人
DECIPHERA PHARMACEUTICALS, INC.;FLYNN, DANIEL, L.;PETRILLO, PETER, A.
